Forensic Analysis · Professional & Commercial Services · as of Nov 9, 2026
Claritev Corp (CTEV)
A forensic read on Claritev Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Clean
Earnings quality
4
Forensic signals
3.7%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Claritev Corp earns a D (Weak — demands caution) forensic quality grade. 4 forensic signals were flagged in its latest SEC filings, led by receivables vs revenue.
What the filings flag
48d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 35 to 48 days FY2024→FY2025 (receivables +42% vs revenue +4%). Receivables are outrunning sales — a flag for aggressive revenue recognition or slipping collections. Across FY2023–FY2025 the day count ran 29 → 35 → 48 days — the latest step continues a climb that was already under way, which is the persistence that separates a collection problem from a busy quarter. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2024's opening balance is on file, but across the 3 fiscal years read here (FY2023–FY2025) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.DSO (days sales outstanding): the average days the company waits to collect cash after a sale.
0.5%
FY2025
Return on invested capital.Return on invested capital is 0.5% in the latest fiscal year, against 1.9% in FY2023, having run between -18.8% and 1.9% across FY2023–FY2025 with no direction held. After-tax operating profit was $128M in FY2023 and $23M in FY2025, with operating income at 16.8% of revenue in FY2023, -149.4% in FY2024 and 3.0% in FY2025. The capital base behind it came down -29% across FY2023–FY2025, from $6.7B to $4.8B, so this return is struck on a smaller base than it started on. FY2024's operating profit carried a $1.5B asset write-down and a $1.4B goodwill write-off that alone took about 39.5 points off that year's return; FY2024 sits between the two ends of FY2023–FY2025, so the charge shapes the path between them without moving the change across it. A non-cash write-down lowers the reported return in the year it lands.
stopped
FY2024→FY2025
Shareholder returns — halted.Capital returns have STOPPED — $10M of buybacks + dividends in FY2024, but ~$0 in FY2025. A halt usually means the company is conserving cash.
$1.4B
FY2024
Goodwill impairments.Took $1.4B of goodwill writedowns across 1 year (FY2024 ($1.4B)). Writedowns mean past acquisitions underperformed what was paid for them.
Key fundamentals
Latest Revenue$965.4M
Revenue Growth YoY+3.7%
Revenue CAGR (2yr)+0.2%
Net Margin-29.4%
Free Cash Flow-$12.3M
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Claritev Corp's actual 10-K/10-Q/8-K filings?